SK282128B6 - Substituované indanylidínacetylguanidíny, spôsob ich prípravy, ich použitie ako liečiva alebo diagnostika a liečivá, ktoré ich obsahujú - Google Patents

Substituované indanylidínacetylguanidíny, spôsob ich prípravy, ich použitie ako liečiva alebo diagnostika a liečivá, ktoré ich obsahujú Download PDF

Info

Publication number
SK282128B6
SK282128B6 SK1034-97A SK103497A SK282128B6 SK 282128 B6 SK282128 B6 SK 282128B6 SK 103497 A SK103497 A SK 103497A SK 282128 B6 SK282128 B6 SK 282128B6
Authority
SK
Slovakia
Prior art keywords
alkyl
carbon atoms
formula
group
compound
Prior art date
Application number
SK1034-97A
Other languages
English (en)
Slovak (sk)
Other versions
SK103497A3 (en
Inventor
Nirogi Venkata Satya Ramakrishna
Arun Kumar Jain
Bansi Lal
Rao Venkata Satya Veerabhadra Vadlamudi
Anil Vasantrao Ghate
Ravindra Dattatraya Gupte
Andreas Weichert
Jan-Robert Schwark
Original Assignee
Hoechst Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Aktiengesellschaft filed Critical Hoechst Aktiengesellschaft
Publication of SK103497A3 publication Critical patent/SK103497A3/sk
Publication of SK282128B6 publication Critical patent/SK282128B6/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/20—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups containing any of the groups, X being a hetero atom, Y being any atom, e.g. acylguanidines
    • C07C279/22—Y being a hydrogen or a carbon atom, e.g. benzoylguanidines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C327/00—Thiocarboxylic acids
    • C07C327/38—Amides of thiocarboxylic acids
    • C07C327/50—Compounds containing any of the groups, X being a hetero atom, Y being any atom
    • C07C327/54—Y being a hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
SK1034-97A 1996-07-30 1997-07-28 Substituované indanylidínacetylguanidíny, spôsob ich prípravy, ich použitie ako liečiva alebo diagnostika a liečivá, ktoré ich obsahujú SK282128B6 (sk)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP96112275A EP0837055A1 (de) 1996-07-30 1996-07-30 Substituierte Indanylidinacetylguanidine als Natrium-Protonen-Antiporter, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikamente oder Diagnostika und sie enthaltende Medikamente

Publications (2)

Publication Number Publication Date
SK103497A3 SK103497A3 (en) 1998-02-04
SK282128B6 true SK282128B6 (sk) 2001-11-06

Family

ID=8223055

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1034-97A SK282128B6 (sk) 1996-07-30 1997-07-28 Substituované indanylidínacetylguanidíny, spôsob ich prípravy, ich použitie ako liečiva alebo diagnostika a liečivá, ktoré ich obsahujú

Country Status (29)

Country Link
US (1) US5900436A (de)
EP (2) EP0837055A1 (de)
JP (1) JP4039589B2 (de)
KR (1) KR980009236A (de)
CN (1) CN1064351C (de)
AR (1) AR008095A1 (de)
AT (1) ATE207888T1 (de)
AU (1) AU715187B2 (de)
BR (1) BR9704131A (de)
CA (1) CA2211982C (de)
CZ (1) CZ241197A3 (de)
DE (1) DE69707777T2 (de)
DK (1) DK0822182T3 (de)
ES (1) ES2164283T3 (de)
HR (1) HRP970424B1 (de)
HU (1) HUP9701316A3 (de)
ID (1) ID17565A (de)
IL (1) IL121407A0 (de)
MX (1) MX9705737A (de)
NO (1) NO308213B1 (de)
NZ (1) NZ328440A (de)
PL (1) PL321392A1 (de)
PT (1) PT822182E (de)
RU (1) RU2176638C2 (de)
SI (1) SI0822182T1 (de)
SK (1) SK282128B6 (de)
TR (1) TR199700704A2 (de)
TW (1) TW445251B (de)
ZA (1) ZA976735B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2657938T3 (es) 2008-12-31 2018-03-07 Ardelyx, Inc. Compuestos y métodos para inhibir el antipuerto mediado por NHE en el tratamiento de trastornos asociados a la retención de líquidos o a la sobrecarga de sales y trastornos del tracto gastrointestinal
WO2018129556A1 (en) 2017-01-09 2018-07-12 Ardelyx, Inc. Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
GB0916163D0 (en) * 2009-09-15 2009-10-28 Shire Llc Prodrugs of guanfacine
ES2735992T3 (es) 2013-04-12 2019-12-23 Ardelyx Inc Compuestos de unión a NHE3 y procedimientos para inhibir el transporte de fosfatos
EP3565808A1 (de) 2017-01-09 2019-11-13 Ardelyx, Inc. Verbindungen zur behandlung erkrankungen des magen-darm-traktes
EA201991676A1 (ru) 2017-01-09 2020-01-30 Арделикс, Инк. Ингибиторы nhe-опосредованного антипорта
JP2022533251A (ja) 2019-05-21 2022-07-21 アルデリックス， インコーポレイテッド 患者において血清リン酸塩を低下させるための組み合わせ

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3929582A1 (de) * 1989-09-06 1991-03-07 Hoechst Ag Benzoylguanidine, verfahren zu ihrer herstellung, ihre verwendung als medikament sowie sie enthaltendes medikament
DE4421536A1 (de) * 1994-06-20 1995-12-21 Hoechst Ag Perfluoralkylgruppen tragende phenylsubstituierte Alkenylcarbonsäure-guanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament

Also Published As

Publication number Publication date
AU3155497A (en) 1998-02-05
CN1064351C (zh) 2001-04-11
CA2211982C (en) 2007-09-18
HRP970424B1 (en) 2002-06-30
KR980009236A (ko) 1998-04-30
EP0822182A1 (de) 1998-02-04
CZ241197A3 (cs) 1998-02-18
DE69707777D1 (de) 2001-12-06
MX9705737A (es) 1998-02-28
NO973486L (no) 1998-02-02
CA2211982A1 (en) 1998-01-30
ATE207888T1 (de) 2001-11-15
RU2176638C2 (ru) 2001-12-10
TR199700704A2 (xx) 1998-02-21
SK103497A3 (en) 1998-02-04
CN1172104A (zh) 1998-02-04
IL121407A0 (en) 1998-01-04
PT822182E (pt) 2002-03-28
EP0822182B1 (de) 2001-10-31
JP4039589B2 (ja) 2008-01-30
NO973486D0 (no) 1997-07-29
NO308213B1 (no) 2000-08-14
BR9704131A (pt) 1998-12-29
NZ328440A (en) 1997-11-24
ES2164283T3 (es) 2002-02-16
HUP9701316A2 (hu) 1998-03-02
PL321392A1 (en) 1998-02-02
DE69707777T2 (de) 2003-01-16
ID17565A (id) 1998-01-08
AU715187B2 (en) 2000-01-20
DK0822182T3 (da) 2002-02-25
HU9701316D0 (en) 1997-09-29
HRP970424A2 (en) 1998-06-30
AR008095A1 (es) 1999-12-09
US5900436A (en) 1999-05-04
JPH1129545A (ja) 1999-02-02
EP0837055A1 (de) 1998-04-22
TW445251B (en) 2001-07-11
HUP9701316A3 (en) 1998-07-28
SI0822182T1 (en) 2002-04-30
ZA976735B (en) 1998-01-30

Similar Documents

Publication Publication Date Title
JPH07109251A (ja) オルト置換ベンゾイルグアニジン、それらの製法、医薬または診断剤としてのそれらの使用およびそれらを含有する医薬
JP3718240B2 (ja) 置換ベンゾイルグアニジン、その製造方法およびそれを含有する医薬
SK282018B6 (sk) Substituované guanididy kyseliny škoricovej, spôsob ich výroby, ich použitie ako liečiva alebo diagnostika, ako aj liečivo, ktoré ich obsahuje
JP3775730B2 (ja) ジアシル−置換されたグアニジン製造用の中間体
RU2160727C2 (ru) Бензоилгуанидины, способ их получения, промежуточное соединение для их получения, способ ингибирования и лекарственное средство
SK282128B6 (sk) Substituované indanylidínacetylguanidíny, spôsob ich prípravy, ich použitie ako liečiva alebo diagnostika a liečivá, ktoré ich obsahujú
SK48396A3 (en) Antiarrhytmic and cardioprotectivly substituted indenoylguanidines
RU2182901C2 (ru) Замещенные 1-нафтоилгуанидины и лекарственное средство на их основе
MXPA97005737A (en) Substitute indianilidinacylukinides, procedure for its preparation, its use as medicines or diagnostic agents and medicines containing them
JP3977897B2 (ja) オルト−置換されたベンゾイルグアニジン、それらの製法、医薬または診断剤としてのそれらの使用およびそれらを含有する医薬
SI9500362A (en) Substituted benzoyl guanidines, process for the preparation thereof, use thereof as a medicine or as a diagnostic agent as well as a medicine containing them
CZ290027B6 (cs) Benzoylguanidin, jeho použití jako léčivo a léčivo tento benzoylguanidin obsahující
SK282440B6 (sk) Substituované guanididy kyseliny tiofenylalkenylkarboxylovej, spôsob ich prípravy, ich použitie ako liečiva alebo diagnostika, ako aj liečivo, ktoré ich obsahuje
JP4160650B2 (ja) オルト置換されたベンゾイルグアニジン、その製造法、医薬または診断剤としてのその使用およびそれを含む医薬
JPH1081662A (ja) ビス−オルト−置換されたベンゾイルグアニジン、その製法、医薬または診断剤としてのその使用およびそれを含有する医薬